Ngā hua rapu kaituhi :: APM

1

A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma mā Diego Bagnasco, Matteo Ferrando, Gilda Varricchi, Giovanni Passalacqua, Giorgio Walter Canonica

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine? mā Gilda Varricchi, Gianenrico Senna, Stefania Loffredo, Diego Bagnasco, Matteo Ferrando, Giorgio Walter Canonica

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma mā Diego Bagnasco, Matteo Ferrando, Gilda Varricchi, Francesca Puggioni, Giovanni Passalacqua, Giorgio Walter Canonica

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
4

The Relevance of Targeting Treatment to Small Airways in Asthma and COPD mā Pierachille Santus, Dejan Radovanovic, Matteo Pecchiari, Matteo Ferrando, Francesco Tursi, Vincenzo Patella, Fulvio Braido

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
5

Personalized Medicine in Allergy mā Matteo Ferrando, Diego Bagnasco, Gilda Varricchi, Stefano Bernardi, Alice Bragantini, Giovanni Passalacqua, Giorgio Walter Canonica

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
6

Anti-IL-5 and IL-5Ra: Efficacy and Safety of New Therapeutic Strategies in Severe Uncontrolled Asthma mā Diego Bagnasco, Marco Caminati, Matteo Ferrando, Teresita Aloè, Elisa Testino, Giorgio Walter Canonica, Giovanni Passalacqua

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i: